Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial (Q35456754)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial |
scientific article |
Statements
1 reference
Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial (English)
1 reference
Karim Fizazi
1 reference
Lance Pagliaro
1 reference
Agnes Laplanche
1 reference
Aude Fléchon
1 reference
Josef Mardiak
1 reference
Lionnel Geoffrois
1 reference
Pierre Kerbrat
1 reference
Christine Chevreau
1 reference
Remy Delva
1 reference
Frederic Rolland
1 reference
Christine Theodore
1 reference
Guilhem Roubaud
1 reference
Gwenaëlle Gravis
1 reference
Jean-Christophe Eymard
1 reference
Jean-Pierre Malhaire
1 reference
Claude Linassier
1 reference
Muriel Habibian
1 reference
Anne-Laure Martin
1 reference
Florence Journeau
1 reference
Maria Reckova
1 reference
Christopher Logothetis
1 reference
Stephane Culine
1 reference
13 November 2014
1 reference
1 reference
Identifiers
1 reference